Discover our new webpage dedicated to 90 years of HA
and download our White paper now!
Press releases
February 28, 2022
Montagu as new investor
February 28, 2022
HTL announces that Montagu, a leading private equity firm, has acquired a majority stake of HTL previously held by Bridgepoint. The other minority shareholders, Naxicap and Téthys Invest, will keep their shares in the company.
The arrival of this new shareholder symbolizes the international success of a company that has become the world leader in the development and production of pharmaceutical grade biopolymers.
To see our most recent news,
follow us on LinkedIn
Read more
news from us
-
Articles November 14, 2024Discover our new webpage dedicated to 90 years of HA and download our White Paper!
and download our White paper now!
-
Articles October 8, 2024HTL Biotechnology at CPHI Milano
As the leading global event for the pharmaceutical industry, CPHI Milan brought together key stakeholders from across the sector to foster connections and innovation.
-
Articles October 4, 20241st symposium for HTL Biotechnology at MAIS congress
As a key event for regenerative medicine and biotech innovation, the MAIS Congress in Marbella brought together leading professionals to explore the latest advancements in the field. A unique opportunity to share with the medical aesthetic community our biopolymers platform.